IMPROVED ANTIBODY TUMOR-TO-NORMAL TISSUE RATIOS BY EXTRACORPOREAL IMMUNOADSORPTION BASED ON AVIDIN-BIOTIN CONCEPT - DEVELOPMENT OF A NEW TREATMENT STRATEGY APPLIED TO MAB L6 AND CHIBR96
M. Garkavij et al., IMPROVED ANTIBODY TUMOR-TO-NORMAL TISSUE RATIOS BY EXTRACORPOREAL IMMUNOADSORPTION BASED ON AVIDIN-BIOTIN CONCEPT - DEVELOPMENT OF A NEW TREATMENT STRATEGY APPLIED TO MAB L6 AND CHIBR96, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 26-26
Citations number
NO
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging","Pharmacology & Pharmacy","Medicine, Research & Experimental